Literature DB >> 32679547

Proteomic analysis of serum-derived extracellular vesicles in ankylosing spondylitis patients.

Yukai Huang1, Fan Feng2, Qidang Huang1, Shaoling Zheng1, Zhixiang Huang1, Weiming Deng1, Xia Pan1, Tianwang Li3.   

Abstract

BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory disease, whose pathogenesis is still unclear. Many studies show the proteins in extracellular vesicle (EVs) would change regularly in many diseases. The study aims to explore the proteins contents of serum-derived EVs in AS patients.
METHODS: EVs were separated by ExoQuickTM kit. The protein profiles of AS patients and healthy subjects were analyzed by Label-free-liquid chromatography mass spectrometry (LC-MS/MS) technology. Enzyme-linked immunosorbent assay (ELISA) was used to verify the levels of the differently expressed proteins. Receiver operation characteristic (ROC) curves and bioinformatic analysis were conducted.
RESULTS: Six hundred and ten serum-derived EVs proteins from AS patients were detected. Seventy-three diferentially expressed proteins were found in AS group, compared with healthy subjects. Of these, 31 proteins were up-regulated in AS group, while 42 proteins were down-regulated. ELISA result showed that EVs-derived serum amyloid A-1 (SAA1) was higher in AS group, which was consistent with the Label-free-LC-MS/MS data. ROC curves result revealed that the area under curve (AUC) value of EVs-derived SAA1 for AS was 0.768 (0.652-0.885). Bioinformatic analysis revealed that the differently expressed proteins in AS group were significantly involved in "complement and coagulation cascades", "staphylococcus aureus infection", "systemic lupus erythematosus" and "PI3K-Akt signaling pathway".
CONCLUSIONS: The protein profiles of serum-derived EVs in AS patients and healthy subjects were different. EVs-derived SAA1 may be a potential biomarkes of AS. The function analysis indicated that the differentially expressed proteins may potentially participate in immune response.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Extracellular vesicles; Immune response; Proteomic

Mesh:

Substances:

Year:  2020        PMID: 32679547     DOI: 10.1016/j.intimp.2020.106773

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  2 in total

1.  Transfer of microRNA-22-3p by M2 macrophage-derived extracellular vesicles facilitates the development of ankylosing spondylitis through the PER2-mediated Wnt/β-catenin axis.

Authors:  Chong Liu; Tuo Liang; Zide Zhang; Jiarui Chen; Jang Xue; Xinli Zhan; Liang Ren
Journal:  Cell Death Discov       Date:  2022-05-23

2.  Serum-derived extracellular vesicles inhibit osteoclastogenesis in active-phase patients with SAPHO syndrome.

Authors:  Yanpan Gao; Yanyu Chen; Lun Wang; Chen Li; Wei Ge
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-04-16       Impact factor: 5.346

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.